Antibody Screening by Microarray Technology-Direct Identification of Selective High-Affinity Clones.
Ontology highlight
ABSTRACT: The primary screening of hybridoma cells is a time-critical and laborious step during the development of monoclonal antibodies. Often, critical errors occur in this phase, which supports the notion that the generation of monoclonal antibodies with hybridoma technology is difficult to control and hence, a risky venture. We think that it is crucial to improve the screening process to eliminate most of the critical deficits of the conventional approach. With this new microarray-based procedure, several advances could be achieved: Selectivity for excellent binders, high-throughput, reproducible signals, avoidance of misleading avidity (multivalency) effects, and performance of simultaneous competition experiments. The latter can also be used to select clones of desired cross-reactivity propert
SUBMITTER: Paul M
PROVIDER: S-EPMC7175374 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA